Cannabis Publications

2022

Kim C, Chum A, Nielsen A, MacMaster F, Rittenbach K, Allin S, O’Campo P, Kirst M, Hamilton H. (2022). Cannabis Legalization and cannabis-Related Hospitalizations in Ontario, Canada. Can J Psychiatry. 27:7067437221114785. doi: 10.1177/07067437221114785.
Williamson N, Hathaway J, Jahrig J, Vik S, Rittenbach K. (2022). Cannabis use and concern among clients seeking substance misuse treatment: demographics, comorbidities, and service utilization patterns pre-legalization (2012-2018). Canadian Journal of Addiction. 13(1): 19-26.

2021

Lee C, Voaklander D, Minhas-Sandhu JK, Hanlon JG, Hyshka E, Dyck JRB, Eurich DT. (2021). Cohort study of medical cannabis authorization and motor vehicle crash-related healthcare visits in 2014-2017 in Ontario, Canada. Inj Epidemiol. 8(1):33. doi: 10.1186/s40621-021-00321-1.
Lee C, Lin M, Martins KJB, Dyck JRB, Klarenbach S, Richer L, Jess E, Hanlon JG, Hyshka E, Eurich DT. (2021). Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada. BMC Public Health. 21(1):843. doi: 10.1186/s12889-021-10867-w.
Lee C, Round JM, Klarenbach S, Hanlon JG, Hyshka E, Dyck JRB, Eurich DT. (2021). Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada. Harm Reduct J. 18(1):61. doi: 10.1186/s12954-021-00509-0.
Lee C, Round JM, Hanlon JG, Hyshka E, Dyck JRB, Eurich DT. (2021). Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada. Can J Psychiatry. 7067437211043393. doi: 10.1177/07067437211043393.
Zongo A, Lee C, Dyck JRB, El-Mourad J, Hyshka E, Hanlon JG, Eurich DT. (2021). Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study. BMC Cardiovasc Disord. 21(1):426. doi: 10.1186/s12872-021-02229-6.
Zongo A, Lee C, El-Mourad J, Dyck JRB, Hyshka E, Hanlon JG, Eurich DT. (2021). Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study Can J Psychiatry. doi: 10.1177/07067437211060597.
Cantor N, Kingsbury M, Hamilton HA, Wild TC, Owusu-Bempah A, Colman I. (2021). Correlates of driving after cannabis use in high school students. Prev Med. 150:106667. doi: 10.1016/j.ypmed.2021.106667. Epub 2021 Jun 1.PMID: 34081937
Sep;150:106667. doi: 10.1016/j.ypmed.2021.106667. Epub 2021 Jun 1.PMID: 34081937
Gibson, M., Williamson, L., Henwood, G., Chalmers, D., Dell, C.D. (2021). Perceptions and use of alcohol and medical cannabis among Canadian military veterans living with PTSD. Journal of Veterans Studies. 7(1), 59–70.

2020

Bahji A, Chinna-Meyyappan A, Hawken E. (2020). Cannabinoids for the neuropsychiatric symptoms of dementia: a systematic review and meta-analysis. Canadian Journal of Psychiatry. 65(6): 365-376.
Bahji A, Chinna-Meyyappan A, Hawken E. (2020). Efficacy and acceptability of cannabinoids for anxiety disorders in adults: a systematic review & meta-analysis. Journal of Psychiatric Research. 129:257-264.
Bahji A, Stephenson C, Tyo R, Hawken ER, Seitz D. (2020). Prevalence of cannabis withdrawal among regular or dependent users of cannabinoids: a systematic review and meta-analysis. Journal of the American Medical Association—Open Network. 3(4): 3095.
Round JM, Lee C, Hanlon JG, Hyshka E, Dyck J, Eurich D. (2020). Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis. BMC Public Health. 20:987. DOI: 1186/s12889-020-09089-3.

2019

Bahji A. (2019). Incidence and correlates of cannabinoid-related psychiatric emergency care: a retrospective, multi-year cohort study. Canadian Journal of Addiction. 11 (1), 14-18.
Bahji A, Stephenson C. (2019). International perspectives on the implications of cannabis legalization: A systematic review & thematic analysis. International Journal of Environmental Research and Public Health. 16(17): 3095.
Eurich D, Lee C, Zongo A, Minhas-Sandhu JK, Hanlon JG, Hyshka E, Dyck J. (2019). Cohort study of medical cannabis authorisation and healthcare utilisation in 2014-2017 in Ontario, Canada. J Epidemiol Community Health. pii: jech-2019-212438.
Jutras-Aswad, D., Le Foll, B., Bruneau, J., Wild, T.C., Wood, E., & Fischer, B. (2019). Thinking beyond legalization: The case for expanding evidence-based options for cannabis use disorder treatment in Canada. Canadian Journal of Psychiatry. 64(2), 82-87.
Lee C, Voaklander D, Minhas-Sandhu JK, Dyck J, Hanlon JG, Hyshka E, Eurich DT. (2019). Cohort study of medical cannabis authorizations and motor vehicle accident-related healthcare visits in 2014-2017 in Ontario, Canada. Revision requested. Injury Prevention.
Watson TM, Valleriani J, Hyshka E, Rueda S. (2019). Cannabis legalization in the provinces and territories: Missing opportunities to effectively educate youth? Canadian Journal of Public Health. 110(4), 472-475.
Watson TM, Hyshka E, Bonato S, Rueda S. (2019). Early-stage cannabis regulatory policy planning across Canada’s four largest provinces: A descriptive overview. Substance Use & Misuse. 54(10), 1691-1704.

2018

Bahji A, Scimeca M, Hurley B, Penders T, Stanciu C. (2018). A Case of Synthetic Cannabinoid Abuse: Summary of Case Conference from American Academy of Addictions Psychiatry 2017 Annual Meeting. American Journal on Addictions. 27: 265-272.
Currie S., Flores-Pajot, M-C., Hodgins D. C., Nadeau, L., Paradis C., Robillard C., & Young M. (2018). A research plan to define Canada’s first Low-Risk Gambling Guidelines. Health Promotion Internationa. 34(6), 1207-1217.
Hodgins, D.C., Stea, J.N. (2018). Insights from individuals successfully recovered from cannabis use disorder: Natural versus treatment-assisted recoveries and abstinent versus moderation outcomes. Addiction Science & Clinical Practice. 13(16), 1-9.
Hodgins, D.C., & Stea, J. (2018). Psychometric evaluation of a lifetime version of the marijuana problems scale. Additive Behaviors Reports 8, 21-24.
Mutti-Packer, S. , Collyer, B. & Hodgins, D. C. (2018). Perceptions of plain packaging and health waning labels for cannabis among young adults: Findings from an experimental study. BMC Public Health. 18(1).

2016

Bahji A, Mazhar MN. (2016). Treatment of Cannabis Dependence with Synthetic Cannabinoids: A Systematic Review. Canadian Journal of Addictions. 7(4):8-13.
Kirst M, Kolar K, Chaiton M, Schwartz R, Emerson B, Hyshka E, Jesseman R, Lucas P, Solomon R, Thomas G. (2016). A common public health-oriented policy framework for cannabis, alcohol and tobacco in Canada? Can J Public Health. 106(8):e474-6.

2015

Stea JN, Yakovenko I, Hodgins DC. (2015). Recovery from cannabis use disorders: Abstinence versus moderation and treatment-assisted recovery versus natural recovery. Psychol Addict Behav. 29(3),522-31.

2011

Hyshka E, Erickson PG, Hathaway A. (2011). The time for marijuana decriminalization has come again . . . and again. Criminal Law Bulletin. 47(2):258-275.
Stea JN, Hodgins DC, Lambert MJ. (2011). Relations between delay discounting and low to moderate gambling, cannabis, and alcohol problems among university students. Behav Processes. 88(3):202-5.

2010

Erickson PG, Hyshka E. (2010). Four decades of cannabis criminals in Canada 1970-2010. Amsterdam Law Forum. 2(4):14.
Hathaway A, Hyshka E, Erickson PG, Asbridge M, Brochu S, Cousineau MM, Duff C, Marsh D. (2010). Whither RDS? An investigation of Respondent Driven Sampling as a method of recruiting mainstream marijuana users. Harm Reduction Journal. 7:15.

2009

Hyshka E. (2009). The Saga Continues: Canadian Legislative Attempts to Reform Cannabis Law in the Twenty-First Century. Canadian Journal of Criminology and Criminal Justice. 51(1), 73–91.
Hyshka, E. (2009). Turning failure into success: what does the case of Western Australia tell us about Canadian cannabis policy-making? Policy Studies. 30(5), 513–531.